Peptide Therapeutics Market to Experience Extensive Growth Thanks to Rising Demands for Improved Healthcare

Changes in lifestyles, increase in environmental pollution, and alteration in dietary habits may lead to the occurrence of several ailments in humans. Thus, a strong need to control these ailments exists, consequently creating a demand for revolutionary treatment methods. One such technique involves utilization of peptides, thus aptly titled as peptide therapeutics. Owing to this method being widely used all over the globe, a distinct peptide therapeutics market exists.

According to expert analysts, the global peptide therapeutics market will capture revenue worth US$46.6 mn by 2024. This is a decent increase from an initial revenue worth US$21.3 bn gained in 2015. This growth is expected to occur with a splendid CAGR of 9.10% during the forecast period from 2016 and 2024.

Increasing Cases of Metabolic Disorders Demand Quality Peptide Treatment Processes

Rising prevalence of various metabolic ailments along with an increasing number cancer cases majorly drives the global peptide therapeutics market. Moreover, with rapid technological advancements, a significant reduction in costs of peptide drug is leading to a surge in preference for utilizing the relevant methodology, thereby boosting growth in the global peptide therapeutics market. Cancer treatments is a key area where peptide therapeutics are expected to be largely utilized in future.

Request a Sample of Report -

Cancer Treatment to Surface as Key Application Area of Peptide Therapeutics

Based on the application, the global peptide therapeutics market is classified into cancer treatment, drugs for metabolic disorders, cardiovascular disease (CVD) therapeutics, respiratory disorder therapeutics, gastrointestinal tract (GIT) therapeutics, anti-infective drugs, dermatology therapeutics, central nervous systems (CNS) therapeutics, and renal therapeutics.

With peptides evolving as a potential therapeutic agent for the treatment of cancer, the cancer segment emerged as the key contributor to this market in 2015. The rising mortality rate, caused by cancer, has led to an increased focus of players towards the development of new drugs and products to combat the situation, which is influencing the market substantially. The technological advancements and extensive research and development activities are likely to fuel the uptake of peptide therapeutics for the treatment of cancer over the next few years.

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research at

Peptide therapeutics mainly follow two routes of administration: Oral and parenteral. The parenteral segment led the global market for peptide therapeutics in 2015 due to the easy availability of peptide drugs for the parenteral route of administration compared to other routes. However, the oral administration of these drugs is likely to increase significantly over the next few years.

Buy Peptide Therapeutics Market Report -

Competition to Intensify with Increasing Number of Players

The global peptide therapeutics market is substantially consolidated owing to the presence of a handful of players. However, with new companies expected to enter the market on a regular basis, the vendor landscape is expected to depict an intensified competition in future. Pfizer Inc., Teva Pharmaceutical Industries Ltd., Eli Lilly and Co., Sanofi, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Co. Ltd., F. Hoffmann-La Roche Ltd., Bachem Holding AG, and Amgen Inc., are key players operating in the global peptide therapeutics market. Most companies are well-established in North America and Europe, with rapid expansions happening in the Asia Pacific region.

More Trending Reports by Transparency Market Research:

Hemoglobin A1c Testing Market: Diabetes is a common health condition among the geriatric population, the prevalence of which is expected to increase over the next few years. This high prevalence of diabetes is expected to drive the growth of the hemoglobin A1C testing market during the forecast period. The global hemoglobin A1C testing market was valued at ~US$ 1 Bn in 2018, and is expected to expand at a CAGR of ~9% during the forecast period.

Sepsis Therapeutics Market: According to the latest report published by Transparency Market Research on the global sepsis therapeutics market for the historical year of 2017 and forecast period of 2019 to 2027, rise in investments in research & development and novel pipeline drugs are projected to boost the growth of the global sepsis therapeutics market during the forecast period.

Synthetic Peptides Market: Artificial peptide synthesis highly influences the production of a wide range of antibodies. Such artificial synthesis helps in inventing unique therapeutic techniques which are highly used for drug discovery, biological research, and product development. All such factors are fueling growth in the global synthetic peptides market.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453

Back to news